Background. Sarcopenia is commonly defined as loss of muscle mass with limited muscle function or strength. Different cutpoints of low lean mass and slow gait speed have been proposed by different professional working groups. We compared the performance of different cutpoints of low lean mass and slow gait speed in predicting death. Methods. We analyzed data of participants aged 65 years or older from the continuous National Health and Nutrition Examination Survey 1999Survey -2004, and the subsequent follow-up data on mortality up to December 31, 2006. For low lean mass, cutpoints based on appendicular lean mass (ALM) alone, ALM adjusted for body mass index (ALM BMI ), and ALM adjusted for height squared (ALM H2 ) were evaluated. For slow gait speed, the cutpoints based on 0.8 and 1.0 m/s were evaluated. A Cox-proportional hazard regression model with adjustment for multiple confounding factors was used for the association analyses. Results. For low lean mass, the cutpoints based on ALM BMI (<0.512 in women and <0.789 in men) showed the most significant association and highest hazard ratio with death (hazard ratio = 1.72; 95% CI: 1.28-2.29). For slow gait speed, all cutpoints tested showed significant association with death in the full model (p < .001), while the cutpoint 0.8 m/s showed the highest hazard ratio (2.32; 95% CI: 1.58-3.39). Conclusions. Low lean mass defined by ALM BMI showed the strongest association with death; while slow gait speed showed significant association with death, with the strongest association being observed for the cutpoint of 0.8 m/s. Further studies validating the cutpoints are warranted before using them in clinical settings.
Sarcopenia is a common geriatric syndrome that is associated with functional limitation and poor clinical outcome, such as increased morbidity and mortality. A large number of studies on sarcopenia have been conducted but different definitions were used. Therefore, different sarcopenia working groups have provided expert opinions on the definition of sarcopenia, including the Asian Working Group for Sarcopenia (1) , The European Society for Clinical Nutrition and Metabolism special interest group (2) , European Working Group on Sarcopenia in Older People (3), International Working Group on Sarcopenia (4), and Society of Sarcopenia, Cachexia and Wasting Disorders (5) . In general, sarcopenia is defined as loss of muscle mass with limited muscle function or strength. Notably, all expert groups agree that low muscle mass (such as appendicular lean mass [ALM] ) is a core component in defining and diagnosing sarcopenia, plus using either slow gait speed or low handgrip strength for confirming diagnosis of sarcopenia.
Different cutpoints have been proposed to define low lean mass (6, 7) and slow gait speed. However, these cutpoints were derived Downloaded from https://academic.oup.com/biomedgerontology/article-abstract/71/1/90/2614173 by guest on 20 December 2018 from modest sample sizes and the clinical relevance of these cutpoints was not clear (8) . Using community-dwelling older individuals data from nine sources, the Foundation for the National Institutes of Health (FNIH) Sarcopenia Project recently derived the clinical relevant low ALM cutpoints as ALM adjusted for body mass index (BMI) (ALM BMI ) <0.789 for men and <0.512 for women (8, 9) . These evidence-based cutpoints are believed to be more clinically relevant (8, 9) . For gait speed, two cutpoints, 0.8 m/s (2,3) and 1.0 m/s (4, 5) , were proposed by professional working groups for defining slow gait speed. Nevertheless, independent study is required to validate the clinical relevancy of various cutpoints recommended by different groups. The primary aim of the current study is to find which definition defines the highest risk of death, and the secondary aim is to compare the performance of various low lean mass and slow gait speed cutpoints in predicting death.
Materials and Methods

Participants
The current study utilized data from National Health and Nutrition Examination Survey (NHANES) 1999-2004 (10) . The NHANES survey included a stratified multistage probability sample which represented the civilian noninstitutionalized U.S. population. Selection was based on counties, blocks, households, and individuals within households. It also included an oversample of non-Hispanic blacks and Mexican Americans to ensure adequate sample size for estimation by race/ethnicity. Participants were required to sign a consent form before their participation, and ethical approval was obtained from the Human Subjects Committee of the U.S. Department of Health and Human Services.
We studied participants aged 65 or above whose non-imputed ALM data were available (N = 2,841). Participants with ineligible Figure 1) . Notably, age, sex, race/ethnicity, and BMI were not significantly different between participants with and without gait speed data (p > .05).
Lean Mass Measurement and Definition of Low Lean Mass
ALM was estimated from the whole body dual-energy X-ray absorptiometry (DXA) scans using a Hologic QDR-4500A fanbeam densitometer (Hologic, Inc., Bedford, MA). Details of the DXA measurement have been described elsewhere (11) . The NHANES lean mass data were adjusted and decreased by 5% due to the overestimation of lean mass by the QDA-4500A algorithm (12) .
In the current study, five cutpoints based on ALM, ALM BMI , and ALM corrected for height squared (ALM H2 ) were used to define low lean mass and the definition and cutpoints for low lean mass are provided in Supplementary Table 1 . The cutpoints (7.0 kg/m 2 for men and 5.4 kg/m 2 for women by DXA) recommended by Asian Working Group for Sarcopenia were not tested in the current study, as these cutpoints are designed for Asians (1) . As the definition of sarcopenia suggested by the Society of Sarcopenia, Cachexia and Wasting Disorders Consensus Sarcopenia with limited mobility is based on "more than 2 standard deviations below that of healthy persons between 20 and 30 years of age in the same ethnic group," we calculated the cutpoints based on the NHANES 1999-2004 participants aged 20-30 with non-imputed DXA data in the current study (N = 2,004). The cutpoints were estimated to be 7.23 kg/m 2 for men and 5.56 kg/m 2 for women.
Gait Speed Measurement and Slow Gait Speed Definition
Time to finish a 20-foot walking test that set up in the mobile exam center was recorded using a hand-held stopwatch by trained and certified health technicians. Gait speed was calculated using the equation "(20 × 0.3048)/time in second" with the unit of m/s. In this study, 2 cutpoints (0.8 and 1.0 m/s) were evaluated.
Mortality Follow-up
In continuous NHANES 1999-2004, the association of various cutpoints of low lean mass with all-cause mortality was evaluated. The NHANES linked-mortality file was created by matching NHANES data with national death index death certificate record (13) . The length of follow-up was the time from the study examination date to death or December 31, 2006, whichever was earlier.
Independent Variables
Age, gender, race/ethnicity, smoking status, and physical activity were assessed using a questionnaire. In NHANES III, there were four race/ethnicity categories: white (non-Hispanic), black (nonHispanic), Mexican American, and "other." We used the same definition for never, current, and former smokers that is used in the National Health Interview Surveys (NHIS) conducted by the Center for Disease Control (http://www.cdc.gov/nchs/nhis.htm). Individuals who had not smoked more than 100 cigarettes (pieces) in their lifetime were considered never smokers; those who had smoked more than 100 cigarettes in their lifetime were considered former smokers if they answered negatively to the question "Do you smoke now?" and current smokers if they answered affirmatively. For alcoholic beverages drinking, individuals who had 12 alcohol drinks or more per year were considered as drinkers (14) . Participants who reported doing moderate or vigorous activity for at least 10 minutes over the past 30 days on the Physical Activity Questionnaire were considered to be physically active (14) . BMI was calculated as weight in kilograms divided by height in meters squared. Diabetes was defined as fasting glucose ≥126 mg/dL; A1C ≥ 6.5; self-report of diabetes; or use of diabetes medications (oral hypoglycemic agents and/or insulin) (14) . The estimated glomerular filtration rate was calculated from the Chronic Kidney Disease Epidemiology Collaboration equation (15) . Microalbuminuria/ albuminuria was defined as albumin-creatinine ratio ≥30 mg/g. Systolic blood pressure (mmHg), serum triglycerides (mg/dL), high density lipoprotein-cholesterol (mg/dL), C-reactive protein (mg/dL), total calcium (mg/dL), phosphorus (mg/dL), aspartate aminotransferase (U/L), alanine aminotransferase (U/L), and alkaline phosphatase (U/L) were also considered as potential confounding factors. Details regarding the measurement of the independent variables are available on the NHANES website (10) . Next, we evaluated the association of these potential confounding factors with lean mass and gait speed, and only included those variables that showed significant association with lean mass or gait speed. For lean analysis, significant association was observed for age, sex, race/ethnicity, BMI, drinking, serum C-reactive protein, serum triglycerides, serum high density lipoprotein-cholesterol, and estimated glomerular filtration rate; whereas age, sex, race/ ethnicity, BMI, drinking, serum aspartate aminotransferase, serum alkaline phosphatase, and microalbuminuria/albuminuria were significantly associated with gait speed. Thus, these variables were adjusted in the full model.
Statistical Analysis
In the Cox-proportional hazard regression model, the hazard ratio (HR) and 95% CI for low lean mass and slow gait speed based on various definitions were calculated using the unadjusted, simple, and full Cox-regression models. In the simple model, age, sex, BMI, and race/ethnicity were adjusted. In the full model, drinking, serum C-reactive protein, serum triglycerides, serum high density lipoprotein-cholesterol, and estimated glomerular filtration rate were further adjusted for low lean mass; and drinking, serum aspartate aminotransferase, serum alkaline phosphatase, and microalbuminuria/albuminuria were further adjusted for slow gait speed. To determine if lean mass and gait speed independently predict death, these two parameters were included in the Cox model simultaneously; interaction term (low lean mass × slow gait speed) was also included in the model to determine if there was any interaction between low lean mass and slow gait speed on death. To determine whether combinations of slow gait speed and low lean mass predict death, participants were categorized into four groups: (a) normal gait speed and normal lean mass; (b) slow gait speed and normal lean mass; (c) normal gait speed and low lean mass; and (d) slow gait speed and low lean mass. "Slow gait speed and low lean mass" was used as reference, and HR and 95% CI were calculated for each of the combinations. Exercise and elevated C-reactive protein were used as strata to avoid deviation from the proportional hazard assumption.
To assess model discrimination, we calculated the area under curve (AUC) for the time-dependent receiver operating characteristic (ROC) using the nonparametric IPCW estimator that accounts for right-censoring. Each of the risk score obtained from the fully adjusted Cox-regression models with different cutpoints was tested, and the difference between two AUCs was compared using the "timeROC" R package.
Sample weights, primary sampling units, and strata that account for the unequal probabilities of selection, oversampling, and nonresponse were applied in all analyses using the complex sampling module in SPSS version 18.0 software (SPSS Inc, Chicago, IL) or R. All values presented are weighted to represent the U.S. civilian population.
Results
The characteristics of the study participants are shown in Table 1 . In participants aged 65 or above, the prevalence of low lean mass ranged from 17.6% to 29.7% in men and from 18.9% to 44.3% in women, depending on the definition (Supplementary Table 2) . Similarly, the prevalence of slow gait speed ranged from 9.4% to 49.1% in men and from 15% to 57.8% in women, depending on the definition (Supplementary Table 3 ). The prevalence of low lean mass and slow gait speed increased with age regardless of gender and definition; 207 (16%) and 123 (10.2%) deaths were observed in men and women, respectively. Table 2 shows the association between various low lean mass cutpoints and death. In the unadjusted model, all cutpoints were significantly associated with death, with the lowest and highest HR being observed for the low ALM (HR = 1.86; 95% CI: 1.42-2.44; p < .001) and low ALM BMI (HR = 1.52; 95% CI: 1.2-1.93; p = .001) cutpoints, respectively. Similar results were observed when age, sex, race/ethnicity, and BMI were adjusted in the model. In the fully adjusted model, all cutpoints derived using ALM H2 became insignificant, whereas the associations with ALM BMI and ALM remained significant, with an HR of 1.72 (95% CI: 1.28-2.29; p < .001) and 1.69 (95% CI: 1.23-2.32; p = .002), respectively. When the analysis was performed in a sex-specific way (Supplementary Table 4) , the only significant association was observed with low ALM (HR = 2.00; 95% CI: 1.35-2.97; p = .001) and low ALM BMI (HR = 1.95; 95% CI: 1.04-3.66; p = .037) for men and women, respectively, whereas the association between low ALM BMI and death in men was marginally significant (HR = 1.51; 95% CI: 1.00-2.30; p = .052). In the ROC analysis, all cutpoints have similar AUCs and not significantly different, with the highest AUC being observed for the model with the cutpoint of ALM BMI (AUC = 0.753 for 54-month prediction, Supplementary Table 5) .
For slow gait speed, both cutpoints (0.8 and 1.0 m/s) were significantly associated with death in all models tested (all p < .001; Table 3 ). The highest HR was observed for the cutpoint 0.8 m/s (HR = 2.32; 95% CI: 1.58-3.39), and followed by 1.0 m/s (HR = 2.11; 95% CI: 1.45-3.08) in the fully adjusted model. Similar association was observed in sex-specific analyses (Supplementary Table 6 ). The AUC of all cutpoints were similar (Supplementary Table 7) .
Participants with both slow gait speed and low lean mass had 2.52-fold (slow gait speed and low ALM BMI in men) to 4.87-fold (slow gait speed and low ALM BMI in women) increased risk of death ( Supplementary Figures 2 and 3) . The group of participants with slow gait speed and normal lean mass had consistent higher risk of death regardless of sex. For participants with normal gait speed and low lean mass, significant associations were observed for the group of "normal gait speed + low ALM" in all participants and "normal gait speed + low ALM BMI " in all participants ( Supplementary Figures 2 and 3) . No significant interaction between lean mass and gait speed on mortality was observed (data not shown).
Discussion
This study showed that low lean mass cutpoints suggested by the FNIH sarcopenia project and gait speed <0.8 m/s were independently associated with death, even after adjustment for multiple confounding factors. These cutpoints appear to be clinically relevant in the U.S. population and warrant further investigation.
Sarcopenia is a prevalent condition in elderly people, which leads to increased risk of functional limitation, morbidity, and mortality. Early identification and intervention may help to arrest the progression of this condition. However, consensus on the definition and specific cutpoints for diagnosis should be reached and validated before identifying patients for intervention. In this study, the low lean mass cutpoints suggested by FNIH appear to perform best in predicting death, at least in women (Supplementary Table 4 ). Although these cutpoints (both ALM and ALM BMI ) were associated with death in the current study, low ALM was the only lean mass parameter shown to be associated with death in men in the FNIH study (9) . Such discrepancy could be due to differences in study design, population studied, and method used for body composition measurement. In addition, participants having low lean mass may also have slow gait speed in the current study, whereas FNIH study excluded participants with existing slow gait speed (defined as gait speed <0.8 m/s), thus analysis by stratifying participants based on low lean mass and slow gait speed status yielded further insight on the association of different combinations of slow gait speed and low lean mass.
All working groups used lean mass divided by height squared (also known as lean mass index) to define low lean mass. Lean mass index is defined in a way similar to BMI with the same unit (kg/m 2 ). However, the clinical usefulness to correct lean mass by height squared remain largely unknown. In the FNIH sarcopenia project, multiple measures of lean mass standardized to body size were evaluated in the CART model to examine which one had the best discriminative power, and found that ALM and ALM BMI were the best discriminators for clinical significant weakness (16) , suggesting that using ALM H2 to define low lean mass may not be as good. On the other hand, all working groups also suggest that low lean mass should be defined using population specific cutpoints based on the young adults in the same population (2) (3) (4) (5) . This concept is similar to the diagnosis of osteoporosis, which is currently based on bone mineral density being 2.5 SD below the young reference mean of the same sex in the same population (ie, bone mineral density T-score <−2.5). Our previous studies showed that handgrip T-score derived from the same sex in the same population was significant associated with multimorbidity (17) and osteoporotic fracture (18) , suggesting that defining a geriatric condition, such as low lean mass and handgrip strength, in this way is well justified.
Compared with low lean mass, the interpretation for slow gait speed is rather straightforward. All cutpoints showed significant associations with death regardless of sex, with the cutpoint of 0.8 m/s having the highest HR when compared with other cutpoints, suggesting that people with gait speed slower than 1.0 m/s may be clinically relevant, whereas people with gait speed lower than 0.8 m/s have the highest risk of having adverse clinical outcome. Gait speed appeared to be a more important predictor of death than low lean mass. Participants with slow gait speed showed consistently higher risk of death regardless of sex and lean mass status. Participants with slow gait speed and low lean mass tended to have even higher risk of death. On the other hand, the association of low lean mass per se with death was inconsistent. This observation is indeed similar to the FNIH sarcopenia project showing that low grip strength (weakness) rather than low lean mass was the predominant predictor of death (9) .
The current findings have important implications. Cutpoint to define sarcopenia should be clinically relevant and a meaningful surrogate for clinically useful end-points (5). Mortality is an important clinical end-point and has commonly been suggested as one of the key clinical outcomes of sarcopenia (1, 3, 5) . Ideally, the optimal cutpoint should be determined based on longitudinal outcomebased studies, whereas using a universal outcome indicator allows comparisons among international studies (1, 5) . Our study identified the lean mass and gait speed cutpoints that defined the highest risk of death in the U.S. population, and provided important information for the development of an international consensus definition of sarcopenia.
This study has several strengths. The study population is large, multiethnic, nationally representative, and well-characterized, with data on both DXA-measured lean mass and gait speed. Nevertheless, there are limitations. First, death record is the only incident clinical outcome available in the NHANES database, whether low lean mass or gait speed is associated with other outcomes remain unknown. Second, the follow-up time was relatively short (less than 10 years), thus limiting the number of deaths in the study.
In conclusion, low lean mass defined by ALM BMI (<0.512 in women and <0.789 in men) showed the strongest association with death, while both cutpoints of slow gait speed showed significant association with death, with the strongest association being observed for the cutpoint of 0.8 m/s.
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